On Tuesday, Veeva Systems stock reached an important technical milestone, with its Relative Strength (RS) Rating entering into the 80-plus percentile with an improvement to 81, up from 66 the day before.
When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength.
This exclusive rating from Investor's Business Daily tracks share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
History reveals that the market's biggest winners often have an RS Rating north of 80 as they begin their biggest runs.
Looking For Winning Stocks? Try This Simple Routine
Is Veeva Systems Stock A Buy?
Veeva Systems stock retook its 200-day moving average in recent weeks. While now is not an ideal time to jump in, see if the stock goes on to form a base and break out. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
The cloud-based medical software company showed 9% EPS growth in its most recent report, while sales growth came in at 16%. The next quarterly results are expected on or around Sep. 1.
Veeva Systems stock earns the No. 4 rank among its peers in the Computer Software-Medical industry group. Evolent Health and Simulations Plus are also among the group's highest-rated stocks.
